BMY Financial Facts
Total Expenses: 3.36BDividends declared per common share: 0.38
See Full Income Statement
Accrued expenses: 4.96B
Accounts payable: 1.41B
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | 10/30/26 *Est. | EPS Growth Rate | +39.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +14.4% | Revenue Growth Rate | +5.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/30/26 | Q226 | $2.04 | $1.61 | +$0.43 | $12.97B | $11.71B | = |  | | Details | |
| 4/30/26 | Q126 | $1.58 | $1.42 | +$0.16 | $11.49B | $10.92B | = | | | Details | |
| 2/5/26 | Q425 | $1.26 | $1.12 | +$0.14 | $12.5B | $12.24B | = | | | Details | |
| 10/30/25 | Q325 | $1.63 | $1.52 | +$0.11 | $12.2B | $11.8B | = | | | Details | |
| 7/31/25 | Q225 | $1.46 | $1.06 | +$0.40 | $12.27B | $11.34B | = | | | Details | |
| 4/24/25 | Q125 | $1.80 | $1.52 | +$0.28 | $11.2B | $10.68B | = | | | Details | |
| 2/6/25 | Q424 | $1.67 | $1.47 | +$0.20 | $12.34B | $11.54B | = | | | Details | |
| 10/31/24 | Q324 | $1.80 | $1.50 | +$0.30 | $11.9B | $11.26B | = | | | Details |
